简体中文 | 繁體中文 | English

Press Releases

2019-04-02 15:18 uLab Systems Opens Office in Shanghai, China to Support Global Expansion
2019-04-02 15:14 Brightcove Completes Acquisition of Ooyala’s Online Video Platform Business
2019-04-02 15:10 SES Reach Grows to 355 Million Homes Worldwide
2019-04-02 13:41 Thales Completes Acquisition Of Gemalto To Become A Global Leader In Digital Identity And Security
2019-04-02 12:24 Toyoda Gosei to Exhibit at Auto Shanghai 2019
2019-04-02 11:27 Superior Assurance for Customers: Smartrac Achieves ARC Quality Certification
2019-04-02 10:30 Onchain Custodian, the Cryptocurrency and Digital Asset Custodian Backed by Sequoia, Fosun and DHVC, Launches its SAFE™ Platform and Value-Added Services
2019-04-02 10:03 Tricor Group Appoints Prasad KNVS as Head of the Shared Services Centre
2019-04-02 10:00 ABB Shows the Factory of the Future to German Chancellor and PM of Sweden
2019-04-02 09:58 ABB and Ericsson Join Forces to Accelerate Wireless Automation for Flexible Factories
2019-04-02 09:54 Terns Pharmaceuticals to Present Preclinical Data on Two Lead Programs at the European Association for the Study of the Liver (EASL) Annual Meeting 2019
2019-04-02 09:51 Health-Related Blockchain MEDIKEY to Reward Participants in Coin If They Become Healthy Through Exercise
2019-04-01 21:38 Kyriba Announces Planned $160M Growth Round Led by Bridgepoint
2019-04-01 17:17 ISACA Names David Samuelson CEO
2019-04-01 15:06 NextDecade to Make Major Announcement at LNG2019 in Shanghai
2019-04-01 13:41 Toshiba’s Arm® Cortex®-M4-based Microcontrollers with Built-in Timers and Communication Channels Achieve High-Speed Data Processing
2019-04-01 13:36 Curtis Arledge Joins Mariner Investment Group as Chairman and CEO and Head of ORIX USA Asset Management
2019-04-01 13:29 Notice of ABB’s Annual General Meeting on May 2, 2019
2019-04-01 13:26 Hyundai Mobis Secures the First Deep Learning Image Recognition Camera Sensor in Korea
2019-04-01 10:05 Celgene Receives CHMP Positive Opinions for Both REVLIMID® (lenalidomide) and IMNOVID® (pomalidomide)-Based Triplet Combination Regimens for Patients with Multiple Myeloma

Business Wire Weibo

Industries

Latest Releases